Lilly Asia Ventures
Hong Konglavfund.com
Overview
Lilly Asia Ventures is a biomedical venture capital firm that invests in biopharmaceuticals, human therapeutics, medical devices, and diagnostics.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Jiajin Biopharmaceutical (Shanghai) Co., Ltd. | Jun 2026 | Series B++ | Lead |
| Avenzo Therapeutics | Jun 2026 | Private Placement | Co-investor |
| Accro Bioscience Inc. | May 2026 | Series C | Co-investor |
| Accro Bioscience | May 2026 | Series C | Co-investor |
| Starna Therapeutics | May 2026 | Series B Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
